Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
In vivo CAR T cell generation to treat cancer and autoimmune disease.
Journal: Science (New York, N.Y.)
Published: June 19, 2025
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial.
Journal: The Lancet. Rheumatology
Published: March 16, 2023
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Journal: Haematologica
Published: August 05, 2022
Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.
Journal: Expert opinion on investigational drugs
Published: April 01, 2021
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Journal: Muscle & nerve
Published: December 03, 2018
Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.
Journal: Kidney international
Published: May 02, 2018
Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.
Journal: The American journal of clinical nutrition
Published: May 15, 2017
Correction: Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study.
Journal: PloS one
Published: December 20, 2016
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.
Journal: Circulation. Heart failure
Published: February 27, 2016
Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States.
Journal: The American journal of cardiology
Published: November 15, 2015
Last Updated: 09/26/2026